TrialHepatology communications2026

Efficacy, safety, and pharmacokinetics of rifaximin in pediatric patients with hepatic encephalopathy in Japan: An open-label study.

Hideaki Okajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.